Floatz logo

Induced Pluripotent Stem Cells (Ipscs)

Sleep Disorder

University of Missouri-ColumbiaCell therapyUnknownActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Sleep Disorder cohort.

Asset / SponsorPhaseRating
Trazodone
Johns Hopkins University
Phase 4BB
Armodafinil
Cephalon
Phase 4BB
Rasagiline
Technische Universität Dresden
Phase 4BB
Olanzapine
Central Institute of Psychiatry, Ranchi, India
Phase 4BB
Melatonin
Duke University
Phase 3BB

View all 34 →

Same molecule, other indications

Induced Pluripotent Stem Cells (Ipscs) is also rated in:

rareActive
D
Indicative · Unknown
30 / 100
View asset →
ataxia telangiectasiaDormant
D
Indicative · N/A
30 / 100
View asset →
global developmental delay with or without impaired intellectual developmentActive
D
Indicative · Unknown
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →